grant

Pathogenic Exosomes in COPD

Organization UNIVERSITY OF ALABAMA AT BIRMINGHAMLocation BIRMINGHAM, UNITED STATESPosted 1 Apr 2023Deadline 31 Mar 2030
NIHUS FederalResearch GrantFY2025A1PIAfrican AmericanAfro AmericanAfroamericanAnimal ModelAnimal Models and Related StudiesAnimalsAntiproteasesAsianBiochemistryBiological ChemistryBlood NeutrophilBlood Polymorphonuclear NeutrophilBody TissuesCOPDCardiologyCaucasianCaucasian RaceCaucasiansCaucasoidCaucasoid RaceCell BodyCell DeathCell-Extracellular MatrixCellsCellular biologyChemistryChronicChronic Obstruction Pulmonary DiseaseChronic Obstructive Lung DiseaseChronic Obstructive Pulmonary DiseaseDNA Molecular BiologyDiseaseDisorderECMEndopeptidase InhibitorsEsteroproteasesExtracellular MatrixExtracellular Matrix DegradationFacultyGoalsGrantGranulocyte ElastaseHumanHuman BiologyImmuneImmunesInflammationLatinaLeukocyte ElastaseLysosomal ElastaseMD studentsMarrow NeutrophilMedical StudentsMentorsMiceMice MammalsMissionModelingModern ManMolecular BiologyMurineMusNHLBINational Heart, Lung, and Blood InstituteNational Institutes of HealthNeutrophil ElastaseNeutrophilic GranulocyteNeutrophilic LeukocyteOccidentalPMN ElastasePathogenicityPathway interactionsPatientsPeptidase InhibitorsPeptidasesPeptide Hydrolase InhibitorsPeptide HydrolasesPeptide Peptidohydrolase InhibitorsPh D studentPh D. studentPh. D. studentPh.D studentPh.D. studentPhD studentPhD. studentPhasePhenotypePhysiciansPhysiologyPolymorphonuclear CellPolymorphonuclear Leukocyte ElastasePolymorphonuclear LeukocytesPolymorphonuclear NeutrophilsPostdocPostdoctoral FellowProtease AntagonistsProtease GeneProtease InhibitorProteasesProtein Kinase InteractionProteinase InhibitorsProteinasesProteolytic EnzymesReceptor-Interacting ProteinResearchResearch AssociateResearch ResourcesResistanceResourcesRoleScientistSmokerSmokingStrategic visionSurfaceTissuesTrainingTranslatingUnited States National Institutes of HealthWorkalpha 1 Antiproteasealpha 1-Antiproteinasealpha 1-Antitrypsinalpha 1-Antitrypsin Trypsin Inhibitoralpha 1-Protease Inhibitoralpha 1-Proteinase Inhibitorcell biologychronic inflammatory diseasechronic obstructive pulmonary disordercigarette smoke exposurecigarette smoke-induceddisease phenotypedoctoral studentexosomeexposure to cigarette smokeextracellularextracellular vesicleshuman diseaseinnovateinnovationinnovativemedical school studentsmembermodel of animalmouse modelmultidisciplinarymurine modelnecrocytosisneutrophilnew diagnosticsnew drug targetnew drug treatmentsnew druggable targetnew drugsnew pharmacological therapeuticnew pharmacotherapy targetnew therapeutic targetnew therapeuticsnew therapynew therapy targetnext generation diagnosticsnext generation therapeuticsnovelnovel diagnosticsnovel drug targetnovel drug treatmentsnovel druggable targetnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel pharmacotherapy targetnovel therapeutic targetnovel therapeuticsnovel therapynovel therapy targetpathogenpathwaypost-docpost-doctoralpost-doctoral traineeprogramspulmonaryresearch associatesresistantsocial roletherapeutic agent developmenttherapeutic developmentwhite raceα1-Antitrypsinα1-Proteinase Inhibitor
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
The thesis of this R35 Program is that immune cell derived “pathogenic exosomes” are

key players in chronic obstructive pulmonary disease (COPD) and that their role can be

modeled in a smoking mouse model of exosome transfer to attain novel understanding of the

disease which can in turn be applied to COPD. This R35 Program is at…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Pathogenic Exosomes in COPD — UNIVERSITY OF ALABAMA AT BIRMINGHAM | UNITED STATES | Apr 2023 | Dev Procure